Premier High-THC Medical Cannabis Hub | GACP & GMP-Certified | 100% Vertically Integrated Colombian Opportunity
Acquire a "Top-Tier" global export hub at a 40% discount to invested capital. Secure a 36-month shortcut to market leadership with a turnkey, debt-free operation featuring €0.30/g production costs, an active EU offtake agreement, and proven export channels to Tier-1 markets.
Listing ID:
16289662234
Licence(s) Held:
GACP Certification (August 2025), TGA GMP Part I (Australia), and EU-GMP Part II approval (via Maltese partnership).
USD $7,000,000 O.B.O (100% share sale)
Listing Details:
Unbeatable Production Arbitrage
Ultra-Low Costs: All-in production costs of €0.30 per gram, with significant downward pressure as the facility reaches its 25+ tonne licensed capacity.
Elite Genetics: Proven high-THC cultivars (mid-20% THC) with sophisticated terpene profiles tailored for the European and Australian markets.
Ideal Climate: Located in a premier micro-climate offering consistent, predictable weather for year-round cultivation.
Institutional-Grade Infrastructure & Scalability
Immediate Capacity: 1.7 hectares of existing, interconnected greenhouses currently producing 5.7 tonnes of dried flower annually.
Expansion Ready: The 15-hectare site is fully licensed for 25+ tonnes, allowing for hyper-growth with minimal additional capex.
Operational Autonomy: Includes a dedicated on-site power sub-station with diesel backup and a 20,000 m³ rainwater reservoir with sophisticated water treatment plant.
Advanced Post-Harvest & Processing Tech
Dual-Track Facility: Separate, dedicated buildings for GACP post-harvest and strict EU-GMP/TGA GMP post-harvest/processing.
Unique Tech Edge: Equipped with Colombia’s only PLC 2500 purification system and a specialized X-ray sterilization system required for the Australian market.
On-Site Lab: Fully equipped laboratory for real-time potency and purity testing to ensure pharmaceutical-grade standards.
Validated Global Export Track Record
Proven Route to Market: One of only a handful of Colombian producers successfully exporting; approximately 1 tonne has already been delivered to European markets.
De-Risked Revenue: Sale includes a binding 3-year offtake agreement and established distribution relationships in Germany and the UK.
Turnkey Transition & Strategic Value
Investment Value: Over USD $12M in capital already deployed in infrastructure, licensing, and elite genetics.
Financial Status: Debt-Free.All related-party debt is forgiven at closing.
The "Shortcut": Bypasses the 3-year "dead period" typically lost to site selection, construction, and complex Colombian regulatory hurdles.
Management Continuity: The majority of the leadership team, including specialized production directors, will remain to ensure a seamless operational handover.
Tax Efficiency: Tax loss carry-forwards (~USD $1.5M) are available through 2036, surviving the share sale structure.
IDEAL BUYER PROFILE
This asset is a "Plug-and-Play" hub for EU, Canadian, or Australian operators looking to protect margins via low-cost supply, or Private Equity/Family Offices seeking a de-risked, asset-backed entry into the global medical cannabis sector.
16289662234
NEW CANNABIS BUSINESSES FOR SALE
See the latest cannabis business listings on the market including dispensaries, cultivation facilities, greenhouses, labs, and more. If you're looking to invest, acquire, or expand, these business opportunities provide the perfect starting point to grow your footprint in the cannabis industry.
28790904174
Licensed 8,500 ft² Cannabis Cultivation & Nursery Facility on 23 Acres Near Montreal, QC for $1.7M OBO
Opportunity to acquire a fully built-out, cannabis cultivation buildings located 30 minutes east of Montreal, featuring two purpose-built cultivation and nursery buildings on 23 acres for 1.7M o.b.o
44498920359
Early-Stage UK Medical Cannabis Platform – Licensed Market Entry Opportunity
Unique opportunity to invest in a pre-operational UK medical cannabis platform being established through a structured regulatory and licensing pathway, led by an experienced sector operator and set to operate all steps from import to patient.
54492796721
Profitable German direct-to-patient medical cannabis platform for €1.95M OBO — €3M+ revenue, 25% profit contribution, fully operational asset package
Unique opportunity to acquire a fully operational, profitable e-health platform serving medical cannabis patients across Germany through an integrated online consultation, prescription, and pharmacy fulfilment model.